Bupropion Hydrochloride
- Product NDC
- 71335-1114
- 11-digit product format
- 713351114
- Labeler code
- 71335
- Product ID
- 71335-1114_99d9c657-4add-4f6e-8c5d-75d888473e23
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA210081
- Marketing category
- ANDA
- Marketing start
- 2018-08-30
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bupropion Hydrochloride
- Brand name suffix
- (XL)
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUPROPION HYDROCHLORIDE | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | ZG7E5POY8O |
| Rxcui | 993557 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 71335-1114-1 | 2024-05-17 | C162847 | 48780-1 | 1030e365-0e58-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets USP (XL), for oral use Initial U.S. Approval: 1985 |
| 71335-1114-2 | 2024-05-17 | C162847 | 48780-1 | 1030e365-0e58-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets USP (XL), for oral use Initial U.S. Approval: 1985 |
| 71335-1114-3 | 2024-05-17 | C162847 | 48780-1 | 1030e365-0e58-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets USP (XL), for oral use Initial U.S. Approval: 1985 |
| 71335-1114-4 | 2024-05-17 | C162847 | 48780-1 | 1030e365-0e58-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets USP (XL), for oral use Initial U.S. Approval: 1985 |
| 71335-1114-5 | 2024-05-17 | C162847 | 48780-1 | 1030e365-0e58-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets USP (XL), for oral use Initial U.S. Approval: 1985 |
| 71335-1114-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-0e58-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets USP (XL), for oral use Initial U.S. Approval: 1985 |
| 71335-1114-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-0e58-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets USP (XL), for oral use Initial U.S. Approval: 1985 |
| 71335-1114-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-0e58-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets USP (XL), for oral use Initial U.S. Approval: 1985 |
| 71335-1114-4 | 2024-01-30 | C162847 | 48780-1 | 1030e365-0e58-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets USP (XL), for oral use Initial U.S. Approval: 1985 |
| 71335-1114-5 | 2024-01-30 | C162847 | 48780-1 | 1030e365-0e58-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets USP (XL), for oral use Initial U.S. Approval: 1985 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-1114-1 | Bupropion Hydrochloride(XL) | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 4 |
| 71335-1114-2 | Bupropion Hydrochloride(XL) | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 4 |
| 71335-1114-3 | Bupropion Hydrochloride(XL) | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | | 4 |
| 71335-1114-4 | Bupropion Hydrochloride(XL) | 120 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 120 | | 4 |
| 71335-1114-5 | Bupropion Hydrochloride(XL) | 8 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 8 | | 4 |
| 71335-1114-6 | Bupropion Hydrochloride(XL) | 180 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 180 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-1114 | BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | Current NDC, Legacy NDC, 6 package rows | 20240913_64be3113-837a-48f3-9f9e-400529c9ee94.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1114-1 | 71335111401 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-1) | 2019-02-22 | 0000-00-00 | No | No | Current |
| 71335-1114-2 | 71335111402 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-2) | 2024-09-05 | 0000-00-00 | No | No | Current |
| 71335-1114-3 | 71335111403 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-3) | 2019-02-21 | 0000-00-00 | No | No | Current |
| 71335-1114-4 | 71335111404 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-4) | 2019-03-29 | 0000-00-00 | No | No | Current |
| 71335-1114-5 | 71335111405 | 8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-5) | 2024-09-05 | 0000-00-00 | No | No | Current |
| 71335-1114-6 | 71335111406 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-6) | 2024-09-05 | | No | No | Historical |